Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001941951 | SCV002233111 | pathogenic | Familial adenomatous polyposis 2 | 2021-06-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with MUTYH-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu423Aspfs*29) in the MUTYH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MUTYH are known to be pathogenic (PMID: 18534194, 20663686). |
Ambry Genetics | RCV004044366 | SCV005038201 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | The c.1269delA pathogenic mutation, located in coding exon 13 of the MUTYH gene, results from a deletion of one nucleotide at nucleotide position 1269, causing a translational frameshift with a predicted alternate stop codon (p.E423Dfs*29). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |